# Benitec Biopharma Inc. (BNTC) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Benitec Biopharma Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BNTC/mda/fy2025/): filed 2025-09-22; accession 0001193125-25-211361 (https://www.sec.gov/Archives/edgar/data/1808898/000119312525211361/d57150d10k.htm); latest 10-K
- [FY 2024 MD&A](/company/BNTC/mda/fy2024/): filed 2024-09-26; accession 0001193125-24-226968 (https://www.sec.gov/Archives/edgar/data/1808898/000119312524226968/d640181d10k.htm)
- [FY 2023 MD&A](/company/BNTC/mda/fy2023/): filed 2023-09-21; accession 0001193125-23-239121 (https://www.sec.gov/Archives/edgar/data/1808898/000119312523239121/d549728d10k.htm)
- [FY 2022 MD&A](/company/BNTC/mda/fy2022/): filed 2022-09-02; accession 0001193125-22-237075 (https://www.sec.gov/Archives/edgar/data/1808898/000119312522237075/d360350d10k.htm)
- [FY 2021 MD&A](/company/BNTC/mda/fy2021/): filed 2021-09-20; accession 0001193125-21-276758 (https://www.sec.gov/Archives/edgar/data/1808898/000119312521276758/d182332d10k.htm)

Back to /company/BNTC/